By Myles Starr
The U.S. federal government is no longer footing the bill for antiviral COVID-19 therapies for every American. The Department of Health and Human Services announced the implementation of a plan to smooth the transition to traditional ordering, distribution and payment for COVID-19 therapies for pharmacies, individuals, manufacturers and the health system at large.
“It is of paramount importance that these medications remain widely accessible to high-risk patients after